Cargando…

Possible role of l‐carnitine in improvement of metabolic and hepatic changes in hyperuricemic and hyperuricemic—Fructose‐supplemented rats

Hyperuricemia was linked to diabetes mellitus, metabolic syndrome, and oxidative stress, and could be induced by higher fructose consumption through altering energy status in liver. l‐Carnitine is an antioxidant, affecting mitochondria and cellular energetics; however, little is known about its effe...

Descripción completa

Detalles Bibliográficos
Autores principales: El‐Kafoury, Bataa M. A., Ahmed, Mona A., Hammouda, Gehad A., ElKady, Amr H., Lasheen, Noha N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882958/
https://www.ncbi.nlm.nih.gov/pubmed/31782919
http://dx.doi.org/10.14814/phy2.14282
_version_ 1783474277768495104
author El‐Kafoury, Bataa M. A.
Ahmed, Mona A.
Hammouda, Gehad A.
ElKady, Amr H.
Lasheen, Noha N.
author_facet El‐Kafoury, Bataa M. A.
Ahmed, Mona A.
Hammouda, Gehad A.
ElKady, Amr H.
Lasheen, Noha N.
author_sort El‐Kafoury, Bataa M. A.
collection PubMed
description Hyperuricemia was linked to diabetes mellitus, metabolic syndrome, and oxidative stress, and could be induced by higher fructose consumption through altering energy status in liver. l‐Carnitine is an antioxidant, affecting mitochondria and cellular energetics; however, little is known about its effects in hyperuricemic states. This study investigated metabolic and hepatic effects of hyperuricemia and fructose feeding, and demonstrated the role of l‐Carnitine in such states. Fifty adult male Wistar rats were randomly divided into control, untreated hyperuricemic, fructose‐supplemented hyperuricemic, l‐Carnitine‐treated hyperuricemic, and l‐Carnitine‐treated fructose‐supplemented hyperuricemic groups. The separated plasma was used for determination of the glycemic control, lipid profile, liver function tests, uric acid level, and oxidative stress markers. Atherogenic index, HOMA‐IR, and body mass index (BMI) were calculated. Left liver lobe and left kidney specimen from all groups were used for histopathological studies. Hyperuricemic rats exhibited significantly hypoalbuminemia, dyslipidemia, insulin resistance, and oxidative stress compared to the controls. Fructose‐supplemented hyperuricemic group showed obesity and more deleterious effects, as well as, steatosis, and renal tubular damage compared to the hyperuricemic rats. Concomitant l‐Carnitine treatment with hyperuricemia improved such effects, despite causing adiposity. While combined l‐Carnitine treatment and fructose supplementation in hyperuricemia limited the aggressive hyperuricemic picture of fructose supplementation. It is concluded that hyperuricemia has detrimental metabolic and hepatic effects. Artificial fructose supplementation worsened such effects, while l‐Carnitine was efficient in ameliorating these hyperuricemia and/or excess fructose‐induced hyperuricemia effects, through its anti‐inflammatory, antisteatotic, and antioxidant properties.
format Online
Article
Text
id pubmed-6882958
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68829582019-12-03 Possible role of l‐carnitine in improvement of metabolic and hepatic changes in hyperuricemic and hyperuricemic—Fructose‐supplemented rats El‐Kafoury, Bataa M. A. Ahmed, Mona A. Hammouda, Gehad A. ElKady, Amr H. Lasheen, Noha N. Physiol Rep Original Research Hyperuricemia was linked to diabetes mellitus, metabolic syndrome, and oxidative stress, and could be induced by higher fructose consumption through altering energy status in liver. l‐Carnitine is an antioxidant, affecting mitochondria and cellular energetics; however, little is known about its effects in hyperuricemic states. This study investigated metabolic and hepatic effects of hyperuricemia and fructose feeding, and demonstrated the role of l‐Carnitine in such states. Fifty adult male Wistar rats were randomly divided into control, untreated hyperuricemic, fructose‐supplemented hyperuricemic, l‐Carnitine‐treated hyperuricemic, and l‐Carnitine‐treated fructose‐supplemented hyperuricemic groups. The separated plasma was used for determination of the glycemic control, lipid profile, liver function tests, uric acid level, and oxidative stress markers. Atherogenic index, HOMA‐IR, and body mass index (BMI) were calculated. Left liver lobe and left kidney specimen from all groups were used for histopathological studies. Hyperuricemic rats exhibited significantly hypoalbuminemia, dyslipidemia, insulin resistance, and oxidative stress compared to the controls. Fructose‐supplemented hyperuricemic group showed obesity and more deleterious effects, as well as, steatosis, and renal tubular damage compared to the hyperuricemic rats. Concomitant l‐Carnitine treatment with hyperuricemia improved such effects, despite causing adiposity. While combined l‐Carnitine treatment and fructose supplementation in hyperuricemia limited the aggressive hyperuricemic picture of fructose supplementation. It is concluded that hyperuricemia has detrimental metabolic and hepatic effects. Artificial fructose supplementation worsened such effects, while l‐Carnitine was efficient in ameliorating these hyperuricemia and/or excess fructose‐induced hyperuricemia effects, through its anti‐inflammatory, antisteatotic, and antioxidant properties. John Wiley and Sons Inc. 2019-11-28 /pmc/articles/PMC6882958/ /pubmed/31782919 http://dx.doi.org/10.14814/phy2.14282 Text en © 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
El‐Kafoury, Bataa M. A.
Ahmed, Mona A.
Hammouda, Gehad A.
ElKady, Amr H.
Lasheen, Noha N.
Possible role of l‐carnitine in improvement of metabolic and hepatic changes in hyperuricemic and hyperuricemic—Fructose‐supplemented rats
title Possible role of l‐carnitine in improvement of metabolic and hepatic changes in hyperuricemic and hyperuricemic—Fructose‐supplemented rats
title_full Possible role of l‐carnitine in improvement of metabolic and hepatic changes in hyperuricemic and hyperuricemic—Fructose‐supplemented rats
title_fullStr Possible role of l‐carnitine in improvement of metabolic and hepatic changes in hyperuricemic and hyperuricemic—Fructose‐supplemented rats
title_full_unstemmed Possible role of l‐carnitine in improvement of metabolic and hepatic changes in hyperuricemic and hyperuricemic—Fructose‐supplemented rats
title_short Possible role of l‐carnitine in improvement of metabolic and hepatic changes in hyperuricemic and hyperuricemic—Fructose‐supplemented rats
title_sort possible role of l‐carnitine in improvement of metabolic and hepatic changes in hyperuricemic and hyperuricemic—fructose‐supplemented rats
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882958/
https://www.ncbi.nlm.nih.gov/pubmed/31782919
http://dx.doi.org/10.14814/phy2.14282
work_keys_str_mv AT elkafourybataama possibleroleoflcarnitineinimprovementofmetabolicandhepaticchangesinhyperuricemicandhyperuricemicfructosesupplementedrats
AT ahmedmonaa possibleroleoflcarnitineinimprovementofmetabolicandhepaticchangesinhyperuricemicandhyperuricemicfructosesupplementedrats
AT hammoudagehada possibleroleoflcarnitineinimprovementofmetabolicandhepaticchangesinhyperuricemicandhyperuricemicfructosesupplementedrats
AT elkadyamrh possibleroleoflcarnitineinimprovementofmetabolicandhepaticchangesinhyperuricemicandhyperuricemicfructosesupplementedrats
AT lasheennohan possibleroleoflcarnitineinimprovementofmetabolicandhepaticchangesinhyperuricemicandhyperuricemicfructosesupplementedrats